Clinical Trial Update: Effects of 5HTP and LDOPA on CNS Excitability After SCI [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating effects of 5-HTP and L-DOPA on CNS excitability after spinal cord injury; the study is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• 5-HTP (5-hydroxytryptophan)
• L-Dopa (Levodopa)

Snippet

Sponsor: Jessica M D'Amico | Conditions: Spinal Cord Injuries | Phase 2, Phase 3 | Status: SUSPENDED